EXTENDICARE INC (EXE.CA) Fundamental Analysis & Valuation

TSX:EXE • CA30224T8639

Current stock price

25.5 CAD
-0.61 (-2.34%)
Last:

This EXE.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. EXE.CA Profitability Analysis

1.1 Basic Checks

  • EXE had positive earnings in the past year.
  • In the past year EXE had a positive cash flow from operations.
  • In the past 5 years EXE has always been profitable.
  • Each year in the past 5 years EXE had a positive operating cash flow.
EXE.CA Yearly Net Income VS EBIT VS OCF VS FCFEXE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

  • The Return On Assets of EXE (10.41%) is better than 92.31% of its industry peers.
  • EXE's Return On Equity of 55.53% is amongst the best of the industry. EXE outperforms 92.31% of its industry peers.
  • EXE has a Return On Invested Capital of 18.54%. This is amongst the best in the industry. EXE outperforms 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for EXE is above the industry average of 7.68%.
  • The last Return On Invested Capital (18.54%) for EXE is above the 3 year average (11.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.41%
ROE 55.53%
ROIC 18.54%
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
EXE.CA Yearly ROA, ROE, ROICEXE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • With an excellent Profit Margin value of 5.72%, EXE belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
  • EXE's Profit Margin has improved in the last couple of years.
  • EXE has a better Operating Margin (8.22%) than 76.92% of its industry peers.
  • In the last couple of years the Operating Margin of EXE has grown nicely.
  • EXE's Gross Margin of 14.15% is on the low side compared to the rest of the industry. EXE is outperformed by 76.92% of its industry peers.
  • In the last couple of years the Gross Margin of EXE has grown nicely.
Industry RankSector Rank
OM 8.22%
PM (TTM) 5.72%
GM 14.15%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
EXE.CA Yearly Profit, Operating, Gross MarginsEXE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. EXE.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EXE is creating value.
  • Compared to 1 year ago, EXE has more shares outstanding
  • The number of shares outstanding for EXE has been reduced compared to 5 years ago.
  • EXE has a better debt/assets ratio than last year.
EXE.CA Yearly Shares OutstandingEXE.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
EXE.CA Yearly Total Debt VS Total AssetsEXE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 3.81 indicates that EXE is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.81, EXE belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
  • The Debt to FCF ratio of EXE is 3.39, which is a good value as it means it would take EXE, 3.39 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.39, EXE is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
  • A Debt/Equity ratio of 1.94 is on the high side and indicates that EXE has dependencies on debt financing.
  • EXE's Debt to Equity ratio of 1.94 is on the low side compared to the rest of the industry. EXE is outperformed by 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.94
Debt/FCF 3.39
Altman-Z 3.81
ROIC/WACC2.5
WACC7.43%
EXE.CA Yearly LT Debt VS Equity VS FCFEXE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 0.81 indicates that EXE may have some problems paying its short term obligations.
  • EXE has a Current ratio of 0.81. This is comparable to the rest of the industry: EXE outperforms 53.85% of its industry peers.
  • A Quick Ratio of 0.81 indicates that EXE may have some problems paying its short term obligations.
  • EXE has a Quick ratio of 0.81. This is in the better half of the industry: EXE outperforms 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.81
EXE.CA Yearly Current Assets VS Current LiabilitesEXE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. EXE.CA Growth Analysis

3.1 Past

  • EXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.52%, which is quite impressive.
  • Measured over the past years, EXE shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.74% on average per year.
  • EXE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.59%.
  • The Revenue has been growing slightly by 5.31% on average over the past years.
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%

3.2 Future

  • Based on estimates for the next years, EXE will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.99% on average per year.
  • Based on estimates for the next years, EXE will show a quite strong growth in Revenue. The Revenue will grow by 15.18% on average per year.
EPS Next Y31.96%
EPS Next 2Y19.6%
EPS Next 3Y18.96%
EPS Next 5Y16.99%
Revenue Next Year15.35%
Revenue Next 2Y24.05%
Revenue Next 3Y18.09%
Revenue Next 5Y15.18%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXE.CA Yearly Revenue VS EstimatesEXE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
EXE.CA Yearly EPS VS EstimatesEXE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

6

4. EXE.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 24.52, which indicates a rather expensive current valuation of EXE.
  • Compared to the rest of the industry, the Price/Earnings ratio of EXE indicates a rather cheap valuation: EXE is cheaper than 84.62% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.23. EXE is around the same levels.
  • Based on the Price/Forward Earnings ratio of 22.34, the valuation of EXE can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, EXE is valued a bit cheaper than the industry average as 76.92% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.28, EXE is valued at the same level.
Industry RankSector Rank
PE 24.52
Fwd PE 22.34
EXE.CA Price Earnings VS Forward Price EarningsEXE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • EXE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EXE is cheaper than 76.92% of the companies in the same industry.
  • 61.54% of the companies in the same industry are more expensive than EXE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 24.16
EV/EBITDA 15.91
EXE.CA Per share dataEXE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of EXE may justify a higher PE ratio.
  • A more expensive valuation may be justified as EXE's earnings are expected to grow with 18.96% in the coming years.
PEG (NY)0.77
PEG (5Y)1.08
EPS Next 2Y19.6%
EPS Next 3Y18.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. EXE.CA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.91%, EXE has a reasonable but not impressive dividend return.
  • EXE's Dividend Yield is a higher than the industry average which is at 1.39.
  • EXE's Dividend Yield is comparable with the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 1.91%

5.2 History

  • The dividend of EXE has a limited annual growth rate of 2.79%.
  • EXE has been paying a dividend for at least 10 years, so it has a reliable track record.
  • EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
EXE.CA Yearly Dividends per shareEXE.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • EXE pays out 45.22% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • EXE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP45.22%
EPS Next 2Y19.6%
EPS Next 3Y18.96%
EXE.CA Yearly Income VS Free CF VS DividendEXE.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
EXE.CA Dividend Payout.EXE.CA Dividend Payout, showing the Payout Ratio.EXE.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EXE.CA Fundamentals: All Metrics, Ratios and Statistics

EXTENDICARE INC

TSX:EXE (3/20/2026, 7:00:00 PM)

25.5

-0.61 (-2.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners23.28%
Inst Owner ChangeN/A
Ins Owners0.96%
Ins Owner ChangeN/A
Market Cap2.41B
Revenue(TTM)1.59B
Net Income(TTM)91.00M
Analysts78
Price Target24.43 (-4.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.91%
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP45.22%
Div Incr Years1
Div Non Decr Years3
Ex-Date02-27
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.07%
PT rev (3m)3.01%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.28%
EPS NY rev (3m)-1.88%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.65%
Valuation
Industry RankSector Rank
PE 24.52
Fwd PE 22.34
P/S 1.51
P/FCF 24.16
P/OCF 15.77
P/B 14.7
P/tB N/A
EV/EBITDA 15.91
EPS(TTM)1.04
EY4.08%
EPS(NY)1.14
Fwd EY4.48%
FCF(TTM)1.06
FCFY4.14%
OCF(TTM)1.62
OCFY6.34%
SpS16.83
BVpS1.74
TBVpS-0.37
PEG (NY)0.77
PEG (5Y)1.08
Graham Number6.37
Profitability
Industry RankSector Rank
ROA 10.41%
ROE 55.53%
ROCE 24.53%
ROIC 18.54%
ROICexc 26.92%
ROICexgc 58.63%
OM 8.22%
PM (TTM) 5.72%
GM 14.15%
FCFM 6.27%
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexgc growth 3Y72.34%
ROICexgc growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score6
Asset Turnover1.82
Health
Industry RankSector Rank
Debt/Equity 1.94
Debt/FCF 3.39
Debt/EBITDA 1.91
Cap/Depr 150.97%
Cap/Sales 3.34%
Interest Coverage 9.89
Cash Conversion 92.12%
Profit Quality 109.55%
Current Ratio 0.81
Quick Ratio 0.81
Altman-Z 3.81
F-Score6
WACC7.43%
ROIC/WACC2.5
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
EPS Next Y31.96%
EPS Next 2Y19.6%
EPS Next 3Y18.96%
EPS Next 5Y16.99%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%
Revenue Next Year15.35%
Revenue Next 2Y24.05%
Revenue Next 3Y18.09%
Revenue Next 5Y15.18%
EBIT growth 1Y30.7%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year10.63%
EBIT Next 3Y17.9%
EBIT Next 5Y14.02%
FCF growth 1Y199.78%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y343.54%
OCF growth 3Y31.32%
OCF growth 5Y26.02%

EXTENDICARE INC / EXE.CA Fundamental Analysis FAQ

What is the fundamental rating for EXE stock?

ChartMill assigns a fundamental rating of 6 / 10 to EXE.CA.


What is the valuation status for EXE stock?

ChartMill assigns a valuation rating of 6 / 10 to EXTENDICARE INC (EXE.CA). This can be considered as Fairly Valued.


What is the profitability of EXE stock?

EXTENDICARE INC (EXE.CA) has a profitability rating of 8 / 10.


Can you provide the expected EPS growth for EXE stock?

The Earnings per Share (EPS) of EXTENDICARE INC (EXE.CA) is expected to grow by 31.96% in the next year.


Is the dividend of EXTENDICARE INC sustainable?

The dividend rating of EXTENDICARE INC (EXE.CA) is 5 / 10 and the dividend payout ratio is 45.22%.